List of Studies ( Metabolite:Margaroyl-EA)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Blood | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Cecum | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Colon | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | DSI | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Liver | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | MSI | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | PSI | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Stomach | Mouse | Brown University | Other | |
| ST003242 | AN005311 | Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. | Kidney | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003242 | AN005311 | Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. | Kidney | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003240 | AN005307 | Lipidomic analysis of liver from Gclc WT and whole-body Gclc KO mice. | Liver | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003240 | AN005307 | Lipidomic analysis of liver from Gclc WT and whole-body Gclc KO mice. | Liver | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003239 | AN005305 | Lipidomic analysis of adipose from Gclc WT and whole-body Gclc KO mice. | Adipose tissue | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003238 | AN005303 | Lipidomic analysis of serum from Gclc WT and whole-body Gclc KO mice. | Blood | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003144 | AN005160 | On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003038 | AN004984 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Liver | Mouse | Diabetes | Vanderbilt University Medical Center | LC-MS |
| ST002977 | AN004887 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | LC-MS | |
| ST002809 | AN004567 | Role of cilia in mitochondrial function | Cultured cells | Dog | Kidney disease | Medical University of South Carolina | LC-MS |
| ST002809 | AN004567 | Role of cilia in mitochondrial function | Cultured cells | Mouse | Kidney disease | Medical University of South Carolina | LC-MS |
| ST002792 | AN004543 | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002691 | AN004364 | MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Untargeted Lipidomics, Reversed-Phase Positive | White adipose | Rat | Georgia Institute of Technology | LC-MS | |
| ST002678 | AN004350 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Untargeted Lipidomics, Reversed-Phase Positive | Liver | Rat | Georgia Institute of Technology | LC-MS | |
| ST002671 | AN004343 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Lung Powder - Untargeted Lipidomics, Reversed-Phase Positive | Lung | Rat | Georgia Institute of Technology | LC-MS | |
| ST002652 | AN004324 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Untargeted Lipidomics, Reversed-Phase Positive | Heart | Rat | Georgia Institute of Technology | LC-MS | |
| ST002645 | AN004317 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Gastrocnemius Powder - Untargeted Lipidomics, Reversed-Phase Positive | Gastrocnemius | Rat | Georgia Institute of Technology | LC-MS | |
| ST002637 | AN004309 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Hippocampus Powder - Untargeted Lipidomics, Reversed-Phase Positive | Hippocampus | Rat | Georgia Institute of Technology | LC-MS | |
| ST002631 | AN004303 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Plasma - Untargeted Lipidomics, Reversed-Phase Positive | Blood | Rat | Georgia Institute of Technology | LC-MS | |
| ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham and Women's Hospital | LC-MS |
| ST002108 | AN003449 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002066 | AN003365 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | Walter and Eliza Hall Institute of Medical Research | LC-MS |
| ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | LC-MS | |
| ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | LC-MS | |
| ST001796 | AN002917 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mesenteric lymph | Mouse | Diabetes | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001795 | AN002915 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mesenteric lymph | Mouse | Obesity | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001275 | AN002116 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001175 | AN001951 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001158 | AN001916 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Feces | Mouse | Johns Hopkins University | LC-MS |
